Upstream Bio, Inc. (UPB) insider trading

Insider

Role

Bought

Sold

Net

Holding

Of company

Worth

Change

AI Upstream LLC entity

10% owner

$19.98M (1)

—

+$19.98M

5,494,410

10.03%

$30.16M

—

Erez Chimovits

Director

$14.03M (2)

—

+$14.03M

4,554,873

8.32%

$25.01M

+3,693%

Orbimed Advisors LLC entity

Director

$14.03M (2)

—

+$14.03M

4,554,873

8.32%

$25.01M

+3,693%

Everett Rand Sutherland

Chief Executive Officer

—

$43.73K (3)

−$43.73K

68,717

0.1255%

$377.26K

—

Aaron Deykin

Chief Medical Officer

—

$18.68K (3)

−$18.68K

32,302

0.0590%

$177.34K

+981.8%

Michael Gray

CFO and COO

—

$17.80K (3)

−$17.80K

27,942

0.0510%

$153.40K

—

Adam Houghton

Chief Business Officer

—

$14.61K (3)

−$14.61K

22,901

0.0418%

$125.73K

—

Allison Ambrose

General Counsel

—

$9.99K (3)

−$9.99K

15,563

0.0284%

$85.44K

—

Wellington Biomedical Innovation Master Investors (Cayman) II L.P.

10% owner

—

894,733

1.63%

$4.91M

—

Upstream Bio, Inc.

What the insiders did Net buying

By person